The immunomodulatory, anti-inflammatory, and antiproliferative properties of vitamin D have laid the basis for a possible function of this prohormone in the pathogenesis of endometriosis. The aim of this case-control study was to investigate vitamin D status, by measuring 25-hydroxyvitamin D [25(OH)D] serum levels, in women with and without endometriosis. Only Italian women of Caucasian origin aged between 18 and 45 years were deemed eligible. Enrollment was limited to the period October to May. Cases and controls were matched for month of recruitment and secondarily for age and parity. Overall, 434 women were enrolled (endometriosis n ¼ 217; controls n ¼ 217). The group of cases included 127 women with ovarian endometrioma and 90 patients with deep endometriosis. Mean (standard deviation) levels of 25(OH)D in women with and without endometriosis were 17.9 (7.0) ng/mL and 18.4 (7.6) ng/mL, respectively (P ¼ .46). Analyzing the two endometriosis subgroups separately, no statistically significant differences emerged (18.7 [7.4] ng/mL in deep endometriosis group vs 17.3 [6.6] ng/mL in women with ovarian endometrioma; P ¼ .14). Comparing the subgroup of women with deep endometriosis with paired controls, no differences occurred (18.7 [7.4] 
Introduction
The immunomodulatory, anti-inflammatory, and antiproliferative properties of vitamin D have laid the basis for a possible function of this prohormone in the pathogenesis of endometriosis. 1 In fact, a dysfunction of the immune system responsible for a state of chronic inflammation has been claimed to play a role in the multifactorial pathogenesis of the disease. 2 Indeed, endometriosis is characterized by a reduced T-cell cytotoxicity, a functional deficit of natural killer lymphocytes, and higher concentration of activated macrophages in the peritoneal fluid, which generate a cascade of cytokines and vascular endothelial growth factors favoring the proliferation of endometrial cells and angiogenesis. 3, 4 Along with this theory, abnormal levels of pro-inflammatory cytokines have been detected in the peritoneal fluid and serum of affected women, 5 and murine models suggested the potential role of interleukin-6 and tumor necrosis factor-a through their effect on inflammatory angiogenesis. 6 Moreover, vitamin D receptor is expressed in ovarian tissue, endometrium, and fallopian epithelial cells, 1 and both eutopic and ectopic endometrium express the enzyme 1a-hydroxylase, responsible for the conversion of 25-hydroxyvitamin D [25(OH)D] into the biologically active form of vitamin D, calcitriol. 7 Of relevance here is a recent study in a murine model of endometriosis showing that calcitriol is able to both prevent ectopic implantation of endometrium and reduce already established lesions. 8 Finally, numerous in vitro and in vivo studies have demonstrated that vitamin D deficiency could increase the risk of several cancer and autoimmune diseases, which tend both to be more common in women with endometriosis. Given this background, the potential role of vitamin D is of increasing interest, and in the past two decades, various studies have investigated the relation between endometriosis and vitamin D serum levels, with inconsistent results (Table 1) . [12] [13] [14] [15] [16] [17] Therefore, the influence of vitamin D on endometriosis development and progression remains to be clarified. To shed more light on this potential association, we have compared serum concentrations of 25(OH)D in a large case-control study of women with and without endometriosis.
Material and Methods
This case-control study was performed in an academic hospital, the Fondazione Ca' Granda-Ospedale Maggiore Policlinico, which includes a tertiary referral center for the study and management of endometriosis. Participants were recruited during the period October 2014 to January 2017. Only Italian women of Caucasian origin aged between 18 and 45 years were deemed eligible. Cases were women with a surgical diagnosis of endometriosis in the previous 24 months or with a current nonsurgical diagnosis of endometriosis. Nonsurgical diagnoses were based on previously published criteria.
18-21 Affected women were subcategorized into two groups, namely, deep invasive endometriosis and ovarian endometrioma. The former included women with rectovaginal plaques, bladder detrusor nodules, bowel lesions, intrinsic ureteral endometriosis, and deep endometriosis infiltrating the pouch of Douglas and parametria. Cases with iatrogenic, postcesarean bladder detrusor endometriosis were excluded. In the same time span, women attending our outpatient clinics for periodic well-woman visits, contraception, cervical cancer screening program, or attending the blood bank of our hospital for blood donation and women without a previous clinical or surgical diagnosis of endometriosis were enrolled as control group. Endometriosis was excluded based on gynecological history, pelvic transvaginal ultrasound, gynecological bimanual examination, and visual inspection of the posterior vaginal fornix. Patients reporting malignancy, uterine leiomyomas, hypertension, diabetes, multiple sclerosis, autoimmune disorders, and coronary, hepatic, or renal diseases were excluded from both study groups. Other exclusion criteria include vitamin D supplementation and full-body sun exposure during the month before study enrollment. Cases and controls were matched for month of recruitment and secondarily for age and parity. Moreover, to prevent the impact of seasonality and the likely Serum levels of 25(OH)D in samples from patients with severe endometriosis were significantly lower than those detected in samples from women with mild endometriosis (P < .01) and controls (P < .05).
interparticipant variable degree of sun exposure, the recruitment was limited to the period October to May.
In women who agreed to participate, a blood sample was drawn. Blood samples were allowed to clot at room temperature and then centrifuged at 2000g for 10 minutes. The resulting serum was stored at À20 C until assayed. The quantitative detection of total 25(OH)D levels was obtained using a commercially available kit based on a chemiluminescence technology (DiaSorin, Inc Corp, Stillwater, Minnesota). The assessments were performed in 3 distinct experiments thawing a similar number of blood samples from matched case and controls. The intra-and interassay coefficients of variation were 10% and 15%, respectively. The biologists engaged in the 25(OH)D assessment were blinded to the condition of the patients and to the study aims.
Data were collected on standardized forms including demographic information and clinical characteristics. In addition, enrolled women filled out a detailed questionnaire evaluating current and previous sun exposure habits, phenotypic characteristics, and skin phototype; the latter has been assessed according to the Fitzpatrick classification, 22 which reflects, to some extent, the degree of skin color intensity and the extent of skin sensitivity to damage generated by ultraviolet (UV) radiation.
In the current study, the concentration of vitamin D is expressed as ng/mL, and severe deficiency, deficiency, insufficiency, and sufficiency were defined when values were <10, <20, !20 to <30, and !30 ng/mL, respectively. 23 The competent institutional review board approved the study, and patients gave written informed consent (Comitato di Etica Milano Area B; determination #1940/2014, approval date September 5, 2014).
Data were archived using Excel 2003 (Microsoft Corporation, Redmond, Washington) and exported in SPSS 18.0 (SPSS, Inc, Chicago, Illinois) for statistical analysis. Data were compared using unpaired or paired Student t test, Fisher exact test, or McNemar test, as appropriate. P values less than .05 were considered statistically significant. As previously adopted by Paffoni et al, 24 the choice of the sample size was calculated based on an expected serum concentration of 25(OH)D in controls of 20.4 (11.8) ng/mL. 13 A difference of À20% in serum 25(OH)D in women with endometriosis was deemed clinically important. Setting type I and type II errors to .05 and .05, respectively, the calculated number of women to be recruited was 434, with 217 per study group.
Results
Recruitment continued until the preplanned number of participants was reached (endometriosis n ¼ 217; controls n ¼ 217). The group of cases included 127 women with ovarian endometriomas and 90 patients with deep lesions. The deep endometriosis group comprised 51 patients with rectovaginal endometriotic plaques, 18 with full-thickness bladder detrusor nodules, 11 with deep lesions infiltrating the pouch of Douglas and parametria, 7 with full-thickness bowel lesions, and 3 with intrinsic ureteral endometriosis. Baseline clinical and gynecological characteristics of cases and controls are shown in Table 2 . The distribution of the demographic variables is similar between the two study groups. Regarding gynecological characteristics, parity did not differ (as expected based on the study design), whereas, as predictable, use of hormonal therapies and pain symptoms (dysmenorrhea, deep dyspareunia, nonmenstrual pelvic pain, and dyschezia) were significantly more frequent in women with endometriosis (Table 2) .
Serum levels of 25(OH)D were 17.9 (7.0) ng/mL in the endometriosis group and 18.4 (7.6) ng/mL in the control group (P ¼ .46). The monthly distribution of serum 25(OH)D in the two study groups is illustrated in Figure 1 . When analyzing the two endometriosis subgroups separately, no statistically significant differences emerged (18.7 [7.4] ng/mL in the deep endometriotic lesions group vs 17.3 [6.6] ng/mL in the ovarian endometrioma group; P ¼ .14). At subgroup analysis, no statistically significant differences were observed when comparing separately women with deep endometriotic lesions and those with ovarian endometriomas with their matched controls (18.7 [7.4] The presence of pain symptoms was determined using the numeric rating scale (NRS) and considering the symptom present if NRS > 5.
no statistically significant differences emerged after subdividing 25(OH)D serum concentrations of the two study groups into the four categories (severe deficiency, deficiency, insufficiency, and sufficiency; P ¼ .29; Table 3 ). A total of 13% (n ¼ 12) of women with deep endometriotic lesions had severely deficient 25(OH)D serum levels, 49% (n ¼ 44) deficient concentrations, 31% (n ¼ 28) insufficient levels, and 7% (n ¼ 6) adequate levels; these figures were not statistically significantly different from those observed in their matched controls (P ¼ .50). The corresponding frequencies for women with ovarian endometriomas were 16% (n ¼ 20), 68% (n ¼ 53), 28% (n ¼ 35), and 3% (n ¼ 4), respectively, also without statistically significant differences with their matched controls (P ¼ .38).
The phenotypic characteristics, current and previous sun exposure habits, and cutaneous reaction to UV are shown in Table 4 . No statistically significant differences emerged between the two study groups. Current and past global UV exposure were comparable between women with and without the disease, being 23.2 (18.7) and 20.9 (14.1) days during adulthood (P ¼ .14) and 43.3 (35.3) and 45.9 (32.3) days during adolescence (P ¼ .44), respectively. The median (interquartile range) duration of last sun exposure prior to enrollment was 14 (7) (8) (9) (10) (11) (12) (13) (14) (15) days in the endometriosis group and 10 (7-15) days in the control group (P ¼ .75), whereas the number of days elapsed between last UV exposure and recruitment was 195 
Comment
In this study, statistically significant differences in 25(OH)D serum levels were not observed when comparing women with and without endometriosis. In addition, no differences emerged after subdividing patients into the phenotypic categories of deep endometriotic lesions and ovarian endometriomas. Lack of differences in UV exposure habits further supports our findings. In both study groups, median 25(OH)D serum concentrations were below the limit of normalcy established by the Endocrine Society guidelines. 23 This questions the validity of this categorization scheme, at least in the Northern Italian context, and supports the opportunity of reconsidering its discriminatory cutoff limits. 25 Indeed, particularly in our Mediterranean country, an insufficient degree of sun exposure may not be deemed the cause of low 25(OH)D serum concentrations.
Our findings are in line with those obtained by Agic et al, 14 whereas in other observational studies higher 13 or lower [15] [16] [17] vitamin D serum levels were observed in women with endometriosis (Table 1) . Noteworthy, the present results are also at odds with previous evidence from our own group. 13 Among the reasons that may explain these inconsistencies, differences in study design and sample size presumably play a role. Unfortunately, studying the impact of vitamin D on the pathogenesis of endometriosis is methodologically challenging. Confounding may bias observational studies, and the disease itself might also theoretically lower vitamin D concentrations (reverse causality bias). 26 Indeed, low 25(OH)D serum levels could result from the inflammatory process, peculiar of endometriotic disease. 27 Environmental factors, such as sun exposure, smoke, obesity, and dietary intake, also influence the levels of vitamin D. 28 To disentangle whether vitamin D may play a role in the pathogenesis of endometriosis, it would be more interesting to test women before disease development, that is, in the adolescent period or even earlier, 29 rather than when the disease is diagnosed at a later age. To this aim, a long-term cohort design would be more appropriate, but also much more costly and cumbersome to conduct. In order to obtain some information on this aspect, we included in our study some questions regarding UV exposure during adolescence and, again, we failed to show any difference between the study groups. This type of evidence is however exposed to a significant risk of recall bias.
One of the advantages of our study design is represented by the large sample size; in fact, none of the previously published observational studies enrolled more than 400 participants. Only the study from Harris et al 15 reporting on the Nurses' Health Study II included a larger sample size, but the study exclusively focused on the estimated nutritional intake of the vitamin that generally represents only 10% of the human needs. In humans, the most relevant source of vitamin D is provided by UV exposure. 9, 30, 31 Matching cases and controls for month of recruitment allowed to elude the relevant potential confounding effect of seasonality. Moreover, to prevent the impact of variable sun exposure, we decided to limit enrollments to the October to May period and to exclude the women who reported a global UV radiation exposure in the month before blood collection. Noteworthy, this latter exclusion criterion should not have biased our results considering that only a minority of patients were excluded on this basis, and this proportion did not differ between the study groups (less than 5% in both groups). In addition, women with disease potentially related to vitamin D deficiency, such as uterine leiomyomas, cancer, multiple sclerosis, or taking vitamin D supplements, were excluded from the study. Finally, the two study groups had similar basal characteristics (geographic origin, body mass index, cigarette smoke, phenotypic, and sun exposure characteristics).
As for any case-control study, the choice of controls may be cause of concern. In our study, we decided to include women without known endometriosis presenting to the gynecological unit for routine well-woman visit, contraception, cervical cancer screening, or to the blood bank of our hospital for blood donation. Endometriosis was ruled out based on gynecological and ultrasonographic examination, but we cannot exclude to have inadvertently included some cases among controls. However, the impact of this potential inaccuracy would be presumably modest, given the limited prevalence of asymptomatic endometriosis in the general population. 32 Moreover, misdiagnoses are more likely for early superficial peritoneal endometriosis, a condition of doubtful clinical relevance. 33 Another potential limitation of our study could be represented by the lack of a food questionnaire investigating the dietary habits of recruited women. However, as mentioned earlier, vitamin D reserve is mostly due to sunlight exposure (90%) rather than dietary intake (10%). 9 In conclusion, the results of the present case-control study do not support an association between serum vitamin D levels and endometriosis. If these findings will be confirmed, the potential role of vitamin D in the development of endometriosis should be challenged.
